Skip to main content
Costa Rica

Resilience System

  • Home
  • Forum
  • Groups
  • Maps
  • Resources
  • Dashboard
    • COVID-19
    • Tropical Weather

User login

  • Create new account
  • Request new password
What is the weather on the sun

Search form

Language

English Arabic Danish Dutch Filipino Finnish French German Greek Haitian Creole Hebrew Hindi Indonesian Irish Italian Japanese Korean Persian Portuguese Russian Spanish Swedish Thai Turkish Ukrainian Vietnamese

Resilience Systems

Global Resilience System

Caribbean Resilience System

Related Links

We Have / We Need

Anonymous's groups in this site

User is not a member of any group.

Your groups across all your sites

User is not a member of any group.

Recent Content

COP28: The climate crisis is also a health crisis
Uganda takes the lead: piloting the Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research
Over 40 million health professionals demand bold health and climate action at COP28
Five grassroots climate justice movements COP28 could learn from
The surprising environmental cost of rapid testing, mosquito nets, and other lifesaving health products

Recent Comments

  • Analysis: New CDC Covid statements appear to contradict Kennedy 2 days 18 hours ago
  • The universal flu vaccine project puzzles vaccine experts  2 weeks 4 days ago
  • New uncertainty into approval of new COVID boosters 1 month 2 days ago
  • HHS top spokesman resigns in dispute with RFK Jr.over measles  3 months 14 hours ago

Who's online

There is currently 1 user online.

  • mike kraft
Facebook  Twitter  RSS

You are here

Home

Treatments

Opinion A new immunity-evading virus variant looms. Here’s how to fight it.

Wed, 2022-10-26 09:49 — mike kraft
Opinion | A new immunity-evading virus variant looms. Here’s how to fight it. Get ready. Another covid wave is on the horizon. Editorial Board Washington Post
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Contagion
Disease
Disease Prevention
Health
Medical Testing
Mutations
Pandemics
Policy
Public Attitudes
Public Health
Science
Social behavior
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
  • Read more about Opinion A new immunity-evading virus variant looms. Here’s how to fight it.
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

Many people still need support despite lifting of COVID-19 precautions--survey

Tue, 2022-10-25 11:18 — mike kraft

First on CNN: Most people feel socially connected as Covid-19 precautions ease, but many still need support, survey finds | CNN

...

Lots of research has been done on links between loneliness, social connection, health and well-being, but a new international survey by the analytics firm Gallup and Facebook’s parent company, Meta, aims to shed some light on exactly how connected people feel and how they connect with others.

They found that most people around the world feel a sense of social connection as Covid-19 precautions ease, but many still need support or help from others – and the factors that drive feelings of connection vary by country.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Disease
Health
Mutations
Pandemics
Public Attitudes
Public Health
Research
Social behavior
Happiness
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report
  • Read more about Many people still need support despite lifting of COVID-19 precautions--survey
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

White House steps efforts to boost new bivalent COVID-19 shots

Tue, 2022-10-25 10:01 — mike kraft

Biden administration amps up efforts to boost new COVID-19 shots | The Hill

President Biden on Tuesday will announce a series of new efforts to boost the administration of the bivalent COVID-19 booster shots, including partnerships with several major companies and pharmacy chains.

...

Medicare will also be sending out email reminders to about 16 million people in the next week informing them of how they can get the updated booster.

...

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Contagion
Disease
Disease Prevention
Government
Health
Mutations
Pandemics
Policy
Public Attitudes
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report
  • Read more about White House steps efforts to boost new bivalent COVID-19 shots
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

Ivermectin still nopt a good COVID-19 Treatment--large new trial

Mon, 2022-10-24 13:01 — mike kraft

Ivermectin: Still on a Losing Streak as COVID-19 Treatment | MedPage Today

WASHINGTON -- There were no differences in relief from mild-to-moderate COVID-19 symptoms for patients on ivermectin versus placebo, according to the ongoing ACTIV-6 trial.

Among >1,000 vaccinated and unvaccinated patients, the median time to recovery was 12 days for those in the ivermectin group and 13 days in the placebo group, reported Matthew McCarthy, MD, of Weill Cornell Medicine in New York City, at IDWeek.

As a result, the hazard ratio for improvement in time to recovery was 1.07 (95% credible interval 0.96-1.17, posterior P=0.91), McCarthy and colleagues stated in JAMA, where the results were simultaneously published.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Data
Disease
Disease Prevention
Government
Medical Testing
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
  • Read more about Ivermectin still nopt a good COVID-19 Treatment--large new trial
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

Omicron subvariants pose a new threat to people with immune deficiencies

Mon, 2022-10-24 09:53 — mike kraft

Omicron subvariants pose a new threat to people with immune deficiencies (nbcnews.com)

New versions of the omicron virus show resistance to the antibody drugs many need for extra protection against Covid.

---

People with compromised immune systems face a new winter of discontent as the ever-mutating omicron virus threatens to outrun the preventive monoclonal antibody cocktail that hundreds of thousands of them have relied upon for extra protection against Covid.

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Contagion
Demographics
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report
  • Read more about Omicron subvariants pose a new threat to people with immune deficiencies
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

Analysis: Falling demand for COVID boosters makes price hikes more likely

Fri, 2022-10-21 17:06 — mike kraft
Analysis: Falling demand for COVID boosters puts price hikes on the table With most Americans delaying or skipping new COVID-19 booster shots, analysts and investors are now predicting far fewer will be given each year, pushing the number of shots well below annual flu vaccinations. Michael Erman Reuters

...

Country / Region Tags: 
Africa
Europe
Germany
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Attitudes
Public Health
Vaccinations
Economics
Problem, Solution, SitRep, or ?: 
Situation Report
  • Read more about Analysis: Falling demand for COVID boosters makes price hikes more likely
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

After the USG stops buying the shots, Pfizer says COVID-19 vaccine will cost $110-$130 per dose

Fri, 2022-10-21 13:15 — mike kraft
Pfizer says COVID-19 vaccine will cost $110-$130 per dose Pfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots, but the drugmaker says it expects many people will continue receiving it for free. AP NEWS

...

Pfizer executives said the commercial pricing for adult doses could start early next year, depending on when the government phases out its program of buying and distributing the shots.

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Disease
Disease Prevention
Government
Health
Mutations
Pandemics
Public Health
Vaccinations
Economics
Problem, Solution, SitRep, or ?: 
Situation Report
  • Read more about After the USG stops buying the shots, Pfizer says COVID-19 vaccine will cost $110-$130 per dose
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

FDA’s vaccines chief sees possibility of more Covid boosters to iprove protection

Fri, 2022-10-21 10:17 — mike kraft
FDA’s vaccines chief sees possibility of more Covid boosters — sooner than he’d like The FDA’s vaccines chief sees the possibility of more Covid boosters for some people before next fall. Helen Branswell STAT

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Boosters
Treatments
Contagion
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Health
Research
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report
  • Read more about FDA’s vaccines chief sees possibility of more Covid boosters to iprove protection
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

U.S. panel votes to add COVID shots to recommended vaccinations

Thu, 2022-10-20 16:42 — mike kraft
Panel votes to add COVID shots to recommended vaccinations NEW YORK (AP) — COVID-19 shots should be added to the lists of recommended vaccinations for kids and adults, a panel of U.S. vaccine experts said Thursday. The panel's unanimous decision has no immediate effect — COVID-19 shots already are recommended for virtually all Americans. AP NEWS

...

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Contagion
Government
Health
Medical Personnel
Pandemics
Policy
Public Health
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report
  • Read more about U.S. panel votes to add COVID shots to recommended vaccinations
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

Moderna COVID vaccine safe, comparably effective in preschoolers ---clinical trial

Thu, 2022-10-20 16:35 — mike kraft
Study: Moderna COVID vaccine safe, comparably effective in preschoolers The vaccine in kids 6 months to 5 years triggered similar immune response and protection as in young adults. CIDRAP
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Data
Demographics
Disease
Disease Prevention
Government
Health
Medical Testing
Mutations
Pandemics
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report
  • Read more about Moderna COVID vaccine safe, comparably effective in preschoolers ---clinical trial
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

Pages

  • « first
  • ‹ previous
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • …
  • next ›
  • last »
Subscribe to Treatments
©Copyright 2021, OVIAR Global Resilience Systems, Inc.
howdy folks
Page loaded in 0.575 seconds.